A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin LymphomaJohn F. Gerecitano, Matthew S. Davids, Lori A. Gressick et al.|Blood|2015Cited by 74